ASX-Dividend-Report-Banner

Archives

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for Platinum-resistant Ovarian Cancer
PRNews

Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for Platinum-resistant Ovarian Cancer

SAN FRANCISCO and SUZHOU, China, March 24, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures...

  • March 24, 2025 11:00 AM AEDT
  • Cision
Asia's First Single Stock Leveraged & Inverse Products to Debut on HKEX
PRNews

Asia's First Single Stock Leveraged & Inverse Products to Debut on HKEX

HONG KONG, March 24, 2025 /PRNewswire/ -- CSOP Asset Management Limited (CSOP), the largest Leveraged & Inverse Products (L&I products) issuer in Hong Kong, is proud to announ...

  • March 24, 2025 11:00 AM AEDT
  • Cision
Strider Named to Fast Company's 2025 List of Most Innovative Companies
PRNews

Strider Named to Fast Company's 2025 List of Most Innovative Companies

Strategic intelligence firm ranked in the top ten for most innovative security company TOKYO, March 24, 2025 /PRNewswire/ -- Strider Technologies, Inc., the leading provider of strategic intellig...

  • March 24, 2025 11:00 AM AEDT
  • Cision
Microsoft CEO Satya Nadella highlights Australia's unique advantage in the AI competition.
Market Updates

Microsoft CEO Satya Nadella highlights Australia's unique advantage in the AI competition.

Highlights:,Australia is enhancing its role in AI development through strong capabilities in application creation and data center management.,Major investments, including Microsoft’s data center expansion, are strengthening technological growth.,Australia...

Cazaly Resources Embarks on Promising Exploration with Goongarrie Gold Project
Market Updates

Cazaly Resources Embarks on Promising Exploration with Goongarrie Gold Project

Highlights,Cazaly Resources (CAZ) initiates a joint venture with Brightstar Resources for the Goongarrie gold project, aiming to secure an 80% stake.,Exploration investments totaling $3 million have commenced under Cazaly Resources, focusing on key prospe...

Clinical Trials and Technological Innovations: A Mixed Landscape
Healthcare Stocks

Clinical Trials and Technological Innovations: A Mixed Landscape

Highlights,Opthea's eye disease trial fails to meet primary endpoints, casting doubts on its future.,HitIQ partners with a major Australian amateur league, aiming to improve concussion detection.,Telix receives FDA approval, extending its prostate cancer ...

Western Yilgarn acquires New Norcia's bauxite-gallium asset
Basic Materials

Western Yilgarn acquires New Norcia's bauxite-gallium asset

Western Yilgarn acquires New Norcia's bauxite-gallium asset

Titanium Sands Initiates Environmental Evaluation for Sri Lankan Project
Basic Materials

Titanium Sands Initiates Environmental Evaluation for Sri Lankan Project

Highlights:,Titanium Sands secures Terms of Reference for Environmental Impact Assessment from Sri Lanka's Central Environment Authority.,The final EIA submission is planned for mid-2025, with an Industrial Mining Licence anticipated afterward.,The projec...

US Bitcoin Reserve: A Revolutionary Move That Could Lead to a DigitalX Reassessment
Technology Stocks

US Bitcoin Reserve: A Revolutionary Move That Could Lead to a DigitalX Reassessment

Highlights:,The US government’s formal recognition of Bitcoin as a strategic reserve asset marks a turning point in global financial policy.,DigitalX remains the only ASX-listed Bitcoin fund manager, uniquely positioned amid rising institutional interest....

Clover Announces U.S. IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB-1019
PRNews

Clover Announces U.S. IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB-1019

-- U.S. IND clearance and revaccination trial initiation supports the differentiated global opportunity for Clover's RSV PreF vaccine (SCB-1019) utilizing validated Trimer-Tag platform -- -- Eval...

  • March 24, 2025 10:56 AM AEDT
  • Cision
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.